用于管理良性前列腺阻塞的治疗算法:当前技术的概述
Thomas Hughes1, Philip Harper2, Bhaskar K Somani3
1Department of Urology, South Warwickshire University Hospital NHS Foundation Trust, Warwick CV34 5BW, UK.
Life (Basel, Switzerland)
|October 28, 2023
概括
良性前列腺阻塞 (BPO) 管理需要个性化治疗算法,考虑到前列腺大小,症状和患者偏好. 综合性评估指导从生活方式改变到先进的手术选择,以改善泌尿功能和生活质量.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 男人的健康 男人的健康
背景情况:
- 良性前列腺阻塞 (BPO) 严重影响生活质量,并造成经济负担.
- 由于全球人口老龄化,BPO的患病率正在增加.
研究的目的:
- 概述一种针对良性前列腺阻塞 (BPO) 的综合管理算法.
- 根据个体患者的因素指导选择适当的治疗方法.
主要方法:
- 对男性下尿道症状 (LUTS) 的诊断评估.
- 管理策略的审查,包括生活方式的修改,医疗治疗 (α阻塞剂,5α减小酶抑制剂) 和手术程序.
- 从传统的通过尿道切除前列腺 (TURP) 到各种微创手术疗法 (MIST) 的手术选择的分类.
主要成果:
- 治疗选择取决于前列腺大小,症状严重程度和患者的偏好.
- 最少侵入性外科治疗 (MIST) 提供了一系列选择,包括霍尔激光核化 (HoLEP),光选择性蒸发 (PVP),水化,Rezūm,前列腺动脉栓塞 (PAE),前列腺尿道升降 (PUL),iTind和Optilume.
结论:
- 个性化治疗选择对于优化BPO管理结果至关重要.
- 影响治疗选择的因素包括患者的偏好,资源的可用性,成本,解剖学和治疗目标.
相关概念视频
Urinary Tract Calculi III: Medical Management
9
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
9
Urinary Tract Calculi VI: Surgical Management
8
Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...
8
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
870
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
870
Urinary Tract Calculi V: Nursing Management
12
AssessmentSubjective Data: Obtain a detailed health history, including any recent or chronic urinary tract infections, periods of immobilization, previous episodes of renal calculi, and medical conditions such as gout, benign prostatic hyperplasia, or hyperparathyroidism. Review the medication history for drugs that may influence stone formation, including allopurinol, analgesics, loop diuretics, or thiazide diuretics. Document the use of long-term indwelling catheters and any past surgical...
12
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
14
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
14
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
177
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
177


